Cabaletta Bio, Inc. — Investor Relations & Filings
Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on developing engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company utilizes its Chimeric Antigen Receptor T cells for Autoimmunity (CARTA) platform to develop treatments that aim to provide deep, durable, and potentially curative responses. Its lead product candidate, rese-cel, is a fully human CD19-CAR T cell therapy designed to transiently eliminate B cells, thereby enabling an "immune system reset." Rese-cel is being advanced in Phase 1/2 clinical trials for a range of autoimmune diseases, including systemic lupus erythematosus, myositis, systemic sclerosis, and generalized myasthenia gravis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| 8-K - Cabaletta Bio, Inc. (0001759138) (Filer) | 2026-05-04 | English | |
| 424B5 - Cabaletta Bio, Inc. (0001759138) (Filer) | 2026-05-04 | English | |
| 8-K - Cabaletta Bio, Inc. (0001759138) (Filer) | 2026-05-04 | English |
Browse filings by year
9 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
DELTA GOLD TECHNOLOGIES LIMITED
Develops and licenses IP for the quantum computing sector u…
|
DGQ | GB | Professional, scientific and te… |
|
DG INNOVATE PLC
Develops sustainable technologies for electric mobility and…
|
DGI | GB | Professional, scientific and te… |
|
Dianthus Therapeutics, Inc. /DE/
Clinical-stage biotech developing therapies for severe auto…
|
DNTH | US | Professional, scientific and te… |
|
DIMERIX LIMITED
Develops GPCR-targeted therapies for inflammatory kidney an…
|
DXB | AU | Professional, scientific and te… |
|
Dogwood Therapeutics, Inc.
A biotech company developing novel therapeutics for pain an…
|
DWTX | US | Professional, scientific and te… |
|
DORSAVI LTD
Develops clinical-grade wearable sensors and software for h…
|
DVL | AU | Professional, scientific and te… |
|
DreamCIS INC.
Contract research organization for pharma, biotech, and med…
|
223250 | KR | Professional, scientific and te… |
|
DT&CRO CO., Ltd.
A full-service CRO providing non-clinical and clinical stud…
|
383930 | KR | Professional, scientific and te… |
|
Dundee Sustainable Technologies Inc.
Develops proprietary, sustainable metallurgical processes f…
|
DST | CA | Professional, scientific and te… |
|
D.Western Therapeutics Institute, Inc.
Biotechnology firm developing drugs from a proprietary prot…
|
4576 | JP | Professional, scientific and te… |
Cabaletta Bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33628/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33628 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33628 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33628 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33628}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cabaletta Bio, Inc. (id: 33628)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.